Quarterly report [Sections 13 or 15(d)]

DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.26.1
DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 04, 2026
Jun. 01, 2026
Jun. 30, 2026
Jun. 30, 2025
Concentration Risk        
Net cash provided by (used in) operating activities     $ 947 $ (16,891)
Net loss     $ (155,293) $ (17,206)
Line of Credit | Amended Revolving Credit Agreement With PNC        
Concentration Risk        
Repayments of long-term debt $ 57,800      
Private Placement        
Concentration Risk        
Number of shares issued in transaction (in shares) 10,615,712      
Proceeds from the sales of stock $ 94,600      
Common Stock | Private Placement        
Concentration Risk        
Number of shares issued in transaction (in shares)   10,615,712    
Proceeds from the sales of stock   $ 94,600